Crouse Hospital has received the American Heart Association’s Get With The Guidelines – Coronary Artery Disease Gold Performance Achievement Award. The award recognizes Crouse’s commitment and success in implementing a higher standard of cardiac care that effectively improves treatment of patients hospitalized with coronary artery disease.
Under the Get With The Guidelines program, patients are immediately started on aggressive risk reduction therapies such as cholesterol-lowering drugs, aspirin, ACE inhibitors and beta-blockers and receive smoking cessation/weight management counseling as well as referrals for cardiac rehabilitation before being discharged. A hospital that receives the Gold Performance Achievement Award has demonstrated for 24 consecutive months that at least 85 percent of its eligible coronary patients are discharged following the American Heart Association’s recommended treatment guidelines.
“The American Heart Association applauds Crouse Hospital for its success in implementing the appropriate evidence-based care and protocols to reduce the number of recurrent events and deaths in cardiovascular disease patients,” states Gregg Fonarow, MD, National Chairman of the Get With The Guidelines Steering Committee. Crouse is the only Syracuse hospital to be recognized with this designation and will be included in an upcoming advertisement placed by the American Heart Association in U.S. News & World Report commending select U.S. hospitals for meeting its cardiac performance improvement standards.
“Crouse Hospital is dedicated to exceeding quality standards in cardiac care, and the Guidelines program helps us accomplish that by making it easier for our team to improve the long-term outcomes of our cardiac patients,” says Dr. Joseph Battaglia, medical director of the hospital’s cardiac care services. Crouse provides a full range of diagnostic and interventional cardiac services and is the region’s only provider of pediatric cardiac catheterization services.
According to the American Heart Association, approximately 610,000 people suffer a new heart attack and 325,000 experience a recurrent heart attack each year. Statistics also show 1.26 million individuals are affected by CAD each year. Additionally, one in five deaths in the United States is caused by CAD.